尿路感染大肠埃希菌耐药分析

    The analysis of drug resistance of Escherichia coli in urinary tract infections

    • 摘要: 目的: 探讨尿路感染大肠埃希菌的耐药性变迁,为临床合理用药提供试验依据。方法: 对2008~2010年度尿标本检出的234株大肠埃希菌进行超广谱β-内酰胺酶(ESBLs)检测和药敏试验,并对药敏结果进行分析。结果: 大肠埃希菌的产酶率呈增高趋势;药敏结果显示大肠埃希菌除对亚胺培南耐药率为0外,对其他常用抗菌药物均出现了不同程度的耐药性,且ESBLs (+)的细菌耐药率普遍高于ESBLs (-)细菌。结论: 尿路感染大肠埃希菌耐药现象严重,尤其是ESBLs (+)株,要不断加强耐药性检测,为临床合理用药提供参考。

       

      Abstract: Objective: To explore the resistance changes of Escherichia coli (E. coli) in urinary tract infection,and provide proofs about the reasonable use of drugs in clinic. Methods: Two hundred and thirty-four strains of E. coli in 2008 to 2010 annual urine specimen with extended-spectrum β-lactamase (ESBLs) detection and drug susceptibility test were detected,and the drug susceptibility results were analyzed. Results: The rate of enzyme production of E. coli showed a rising trend;the drug sensitivity test showed that the resistance existed in normal antibiotics was in different degrees except for Imipenem,and the rate of medical resisitance in ESBLs (+) bacteria was higher than in ESBLs (-). Conclusions: The resistance of urinary tract infection which caused by E. coli especially in ESBLs (+) strains is so serious. It should be strengthen in the detections of the medical resistance,which provide the references for the clinic rational drug use.

       

    /

    返回文章
    返回